Skip to content
Call Us Today! 1 (772) 595-9830 info@midwayresearch.com
FacebookTwitterLinkedInInstagram
Midway Research Center Logo Midway Research Center Logo Midway Research Center Logo
  • Home
  • About
  • Clinical Trials
    • Currently Enrolling Studies
    • Active, not recruiting Studies
    • What is a Clinical Trial?
    • Expectations
    • Studies Phases
    • Informed Consent
    • Closed Studies
  • Services
    • HIV
    • STD
    • HPV
    • Lipodystrophy
  • Journal Publications
  • Contact
  • Home
  • About
  • Clinical Trials
    • Currently Enrolling Studies
    • Active, not recruiting Studies
    • What is a Clinical Trial?
    • Expectations
    • Studies Phases
    • Informed Consent
    • Closed Studies
  • Services
    • HIV
    • STD
    • HPV
    • Lipodystrophy
  • Journal Publications
  • Contact

Expanded Access Treatment Protocol: Remdesivir for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)

Home/Expanded Access Treatment Protocol: Remdesivir for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)
Expanded Access Treatment Protocol: Remdesivir for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)midwayadmin2020-05-19T15:28:26+00:00

Expanded Access Treatment Protocol: Remdesivir for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)

GS-US-540-5821 · Trial ·

Major Inclusion/Exclusion Criteria:

  1. Hospitalized with confirmed positive COVID-19 test
  2. 18 years or older
  3. On ventilator or tracheostomy

Read more

© Copyright 2012 -    |   AVADA THEME BY THEMEFUSION   |   ALL RIGHTS RESERVED   |   POWERED BY WORDPRESS
FacebookTwitterLinkedInInstagram